OPUS IP
      
 
  • Home
  • ABOUT OPUS IP
  • PROTECTION
  • IP OFFICES
  • UKIPO
  • NEWS/UPDATES
  • RECENT HEARINGS
  • PATENTS
  • TRADEMARKS
  • DESIGNS
  • UK IPEC DECISIONS
  • EPO
  • NEWS/UPDATES
  • APPEAL DECISIONS
  • G/XX DECISIONS 2010-2019
  • G/XX DECISIONS 2000-2009
  • G/XX DECISIONS 1990-2000
  • G/XX DECISIONS PRE-1990
  • J/XX APPEALS 2010-2019
  • J/XX APPEALS 2000-2009
  • J/XX APPEALS 1990-2000
  • J/XX APPEALS PRE-1990
  • T/XXXX APPEALS 2010-2019
  • T/XXXX APPEALS 2000-2009
  • T/XXXX APPEALS 1990-1999
  • T/XXXX APPEALS pre-1990
  • WIPO – PCT/MADRID/HAGUE
  • NEWS/UPDATES
  • PCT NEWSLETTER
  • PATENTS NEWS
  • TREATY MODIFICATIONS
  • MADRID SYSTEM (TM)
  • HAGUE SYSTEM (DESIGNS)
  • PATENTSCOPE/SEARCHING
  • USPTO
  • NEWS/UPDATES
  • GENERAL
  • PATENTS
  • TRADEMARKS
  • COPYRIGHT
  • EUIPO
  • NEWS/UPDATES
  • SEARCH CASES (EXTERNAL)
  • IP NEWS/LINKS
  • LINKS TO IP RESOURCES
  • SITE
  • LOG-IN
 

Temporary unavailability of new online filing (CMS) on Saturday, 27 March 2021

25th March 2021

http://www.epo.org/service-support/availability-of-online-services/2021/20210324.html
Content reproduced from the Website of the European Patent Office as permitted by their terms of use.

Owing to technical maintenance work, new online filing (CMS) will be temporarily unavailable on Saturday,
27 March 2021, between 08:00 and approximately 12:00 hrs CET. To continue to file online during this downtime,
please use
Online Filing
or the web-form filing service. We apologise for any inconvenience.

 
 
 
 

OPUS IP on X (formerly Twitter)…

Twitter feed is not available at the moment.
 
 
 

RSS RECENT PATENT NEWS…

  • Firm Advises PepStar Therapeutics on Patent Matters Related to Acquisition of Inflammation Drug Program by Gilead Sciences - Wilson Sonsini
  • Asked & Answered with Baker Botts IP Litigator Doug Kubehl: Erasing a $847M Verdict and 30 Years in Dallas - The Texas Lawbook
  • Stellantis Patents A Secret Head-Up Display You'll Only Be Able To Access By Speeding - CarBuzz
  • AbbVie’s Dividend Survived Humira’s Patent Cliff. Will Merck and Amgen’s? - 24/7 Wall St.
 
 

RSS UK BUSINESS NEWS…

  • White House lifts tariffs on some Canadian goods as midterm elections loom
  • The little-known investment Martin Lewis wants you to understand...
  • Civil servant who juggled five jobs says he was 'surprised' to be charged with fraud
  • What is PHP and why did it spark a global cyber-security scramble?
 
 
 

Designed by Industrial Action

Copyright © 2026 OPUS IP Limited. All Rights Reserved

OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION